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Abstract
Venomous snake bites in pregnant women can lead to poor survival rates in 
both the foetus and mother; early bites can precipitate teratogenesis, miscarriages, 
preterm delivery, foetal death and antepartum haemorrhage. The chicken embryo 
poses as a valuable research model for venom research due to its advantages such as 
ease of availability, economic feasibility and its non-invasiveness. This study evalu-
ates the embryotoxic effects of Puff adder venom (Bitis arietans) from Namibia, 
Kenya, South Africa and non-specified region of Africa at varying concentrations. 
The venoms were applied to chicken embryos on the fourth day of incubation and 
assessed on a ninth day, focusing on body weight, heart weight, liver weight and 
mortality rate. Nile blue staining was also performed to observe the occurrence of 
apoptosis amongst the venoms at the strongest concentrations. The information 
provided from our results suggested that there was a regional variation in venom 
toxicity, with the Kenyan venom producing the largest weight changes, whereas 
the non-specified African venom proved the most lethal across the concentrations. 
Further studies to assess venom protein concentrations in comparison with regional 
diet disparities are required.
Keywords: Bitis arietans, chicken embryo, development, embryotoxicity,  
snake venom
1. Chicken embryo as an animal model for biomedicine
The chick embryo has established itself within biomedical science as a crucial 
research model due to its similarity on a cellular and anatomical level to human 
embryos along with its rapid development, easy visibility and manipulation [1]. The 
cardiovascular system in the avian develops rapidly with the added benefit of the 
embryo remaining transparent during morphological development of primary organs, 
allowing visibility of vasculature formation using simple microscopy techniques [2].
1.1 Transgenic chicken egg as a bioreactor
The use of a chick egg as a bioreactor has been promoted over the use of stan-
dard large-scale fermenters due to its ability to produce large quantities of complex 
proteins and cheaper running costs [3]. A 2002 study placed a retroviral vector 
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based on avian leucosis virus into the chicken genome and noted that biologically 
active enzymes were secreted into the serum and egg white of four generations of 
chickens. The levels of enzyme expression remained steady through each succes-
sive generation and remained constant for over 16 months in the magnum of hens 
indicating the expression of this enzyme was stable. This supports the possibility 
of chicken eggs in the role of a bioreactor for the production of biologically active 
proteins for therapeutic interest [4]. Human interferon a2b and β1a along with 
human granulocyte-colony stimulating factor have been successfully harvested 
from this method [5]. The egg is an ideal model for the recovery of these proteins as 
the content is sterile and provides a long half-life [6]. Production of human proteins 
in hens could become the method of choice for proteins that are toxic to mammals, 
an example of this is human erythropoietin which is damaging to the mammary 
gland of rabbits but remains inactive in chickens [7].
1.2 Chicken egg used for drug screening and production
The avian chorioallantoic membrane (CAM) refers to the outermost membrane 
that is highly vascularised for gas exchange and calcium transportation between 
the embryo and its environment [8]. It has been widely used to discover targets 
and measure the in vivo angiogenic effects of factors such as vascular endothelial 
growth [9] and P13 kinase [5]. The chorioallantoic membrane provides advanta-
geous exposure to the embryo with minimal invasiveness [5]. The chicken egg is a 
reliable candidate in assessing angiogenic responses to drugs as well as being cost 
and time-effective [10]. In 1984, inactivated rabies vaccine for human use was 
developed which had been adapted to proliferate in primary chick egg cultures [11]. 
This vaccine provided similar antigenicity to the human diploid cell strain with 
the advantages of cheaper and faster production. This purified chick embryo cell 
culture vaccine has now been licenced in over 60 countries worldwide for 30 years 
[12]. The influenza vaccine has been developed in the embryonated chicken eggs 
since the 1940s, the egg provides high titre capabilities and large-scale production 
opportunity which has led to the streamlined process of today which provides vac-
cination for millions worldwide [13].
1.3 Chicken egg used in retinal development
The chicken embryo is advantageous in studying retinal development due to its 
significant similarity to the human embryo at a molecular, cellular and anatomi-
cal level and its rapid development [1]. It is an important model in regenerative 
research as the neural retina can regenerate from the pigmented epithelium as late 
as stage 24 [14]. The regeneration can occur from the cup margin or patches of 
pigmented epithelium far from the margin. The lens does not have to be present for 
the regeneration, and the regenerating tissue develops faster than normal [14]. The 
chicken model is used in the vision research community to study human retinogen-
esis and develop new ways to battle human blindness and eye disease by allowing 
scientists an insight into the complex regulatory network of neurons and glial cells 
[15]. In America, diabetic retinopathy is the leading cause of blindness amongst 
over 40-year-olds [16] with all type 1 diabetes developing DR and more than 60% 
with type 2 [17]. Chickens, like humans, are diurnal with complex colour vision and 
as their retina is cone-dominant it makes them an ideal model for photoreceptor-
degenerative blindness [18]. In a 2014 study, chicken embryos were injected with 
either streptozotocin or high concentration of glucose at day 11; in both groups, 
cataracts occurred in varying degrees making them a promising animal model for 
diabetes research [19].
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1.4 Chicken embryo as an animal model for research in Alzheimer’s disease
Studies by Murphy and LeVine [20] and Carrodeguas et al. [21] revealed that 
the chick embryo has an active process for the formulation and degeneration of the 
amyloid-beta peptide deposits associated with Alzheimer’s disease. The distribution 
of the peptide sequence in chick embryos is similar to humans, predominating in the 
nervous system. This study also discovered that the chick embryo produces neprilysin 
(ADAM-17), a protease that degrades the peptide [21]. Due to the easy access of chick 
embryos, it’s an ideal candidate for developing a potential system for drug regulation 
and regression for this neurodegenerative disease [22]. In a 2003 study, the chick 
embryo was a model for supporting the use of Ginkgo biloba extract as Alzheimer’s 
therapy. The embryo was exposed to cyanide, with and without therapeutic use of the 
extract. Results show an increase function in cultured neurons from the telencephalon 
and a reduction in apoptotic damage caused by serum deprivation after 24 hours [23].
1.5 The role of the chicken embryo in oncology research
The chick embryo allows the unique research of oncology in vivo. Along with 
being highly accessible and easy to manipulate, the CAM is naturally immune-
deficient which can support engraftment of both normal and cancerous tissue up 
until developmental day 18 [24]. The CAM has also been used for research into 
carcinogenesis [25] and tumour angiogenesis [26]. In 1911, by inoculating the 
Rouse Sarcoma virus into chick embryos, it was suggested for the first time that 
viruses could cause cancer [27]. It is now estimated that 15–20% of human cancers 
worldwide involve tumour inducing viruses, such as T-cell leukaemia virus type 1 
and hepatitis C [28]. In 2002, Zijlstra et al. [29] developed a highly sensitive assay 
to monitor metastatic dissemination of human cancer cells in the chick embryo by 
using the CAM as an established biological platform. In 2014, Mu et al. concluded 
that chicken embryo extract may promote the reversion of metastatic phenotypes of 
osteosarcoma cells, which could lead to tumour reversion through epigenetics [30].
1.6 Role of the chicken embryo in stem cell research
In 1996, Pain et al. displayed that early chicken blastoderm cells or avian embry-
onic stem cells can be maintained in vitro for long term culture. These cells model 
traits of murine stem cells in morphology, reactivity to antibodies and high telomer-
ase activity along with the high capability to differentiate into various cell types [31]. 
When blastoderm embryonic stem cells are grafted onto the CAM, they organise 
into complex structures such as embryoid bodies and derivatives of the three 
primary germ layers. These cells can provide an in vitro model of cell differentiation 
and maturation along with means of targeted genome control [32]. Germline stem 
cell research is associated with the manufacture of transgenic animals using male 
spermatogonial stem cells [33] for the production of pharmaceutical proteins [34]. 
Recently direct reprogramming has been created to convert differentiated somatic 
cells into pluripotent embryo stem-like cells; this is an advantageous medical method 
avoiding ethical issues surrounding human egg use [33]. Amniotic stem cells isolated 
from the amniotic cavity can create clonal cell lines and due to their ease of isolation, 
are considered a potential source for regenerative medicine application [35].
1.7 Chick embryotoxicity screening test
Developed by Jelinek in 1977 the chick embryotoxicity screening test (CHEST) 
is a standardised technique to allow administration of small amounts of test 
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compounds and the quantitative measurement of results. This method is advanta-
geous as it requires limited materials. Fertilised eggs, micropipettes for administra-
tion, incubator and a dissection kit are all that is needed. The CHEST test allows 
the use of a chick embryo to study experimental teratogenicity. The number of 
dead, malformed, and growth-retarded foetuses (weight <650 mg and with no 
malformation) are totalled for each concentration and stage of the embryo at the 
time of exposure. The proportion of affected embryos is plotted against the concen-
tration of test compound, and the embryo-stage of administration. The proportion 
of effects on particular organs in surviving embryos is considered separately to 
establish a profile of effects for each compound [36]. The screening test has been 
used to determine the toxicity of many substances, establishing parameters of 
dose–response and stage-response [37].
2. Snake venom
2.1 The role of snake venom
Venom is defined as ‘a secretion, produced in a specialised gland in one animal 
and delivered to a target animal through the infliction of a wound, which contains 
molecules that disrupt normal physiological or biochemical processes to facilitate 
feeding or defence’ [38].
Venom is composed of proteins and polypeptides, it has two primary func-
tions—to paralyse their prey and start the digestive process with hydrolysing pro-
teins leading to tissue necrosis and blood clotting [39]. These venom components 
can be grouped according to the mode of action:
1. Binding to cholinergic receptors, often leading to respiratory muscle paralysis.
2. Inhibition or increase release of acetylcholine, causing muscle cells to not 
react to nerve stimulus, leading to spasms, damage of the skin and disruption 
 connective tissues.
3. Cytotoxic and cardiotoxic, which harm cell membranes and disrupt the 
 transport of substances across the membranes [39].
In broad terms, snake venoms are classified as inflammatory, cytotoxic, neuro-
toxic or haemotoxic [40].
2.2 The venom delivery system
Many snakes use fangs, specialised dentition associated with the venom gland 
(Duvernoy gland) to introduce venom into prey. Fangs can either be posteriorly 
(grass snake) or anteriorly (vipers) positioned within the upper jaw [41].
Many poisonous snakes possess different types of dentition; vipers and atrac-
taspidids have a shortened maxilla which rotates allowing the fangs to move; 
whereas elapids fangs are fixed at the front of the maxilla. Colubrids can possess 
an enlarged rear positioned fang or no fang at all. The venom gland, also known 
as the Duvernoy gland in posteriorly positioned fanged species, is innervated by 
the maxillary branch of the trigeminal nerve, facial nerve and supplied by the 
internal carotid artery [42]. The Duvernoy gland is positioned posteriorly to the 
eye, encased in a thin layer of connective tissue and consists mainly of serous cells; a 
single duct extends from the gland to the base of the fang; whereas the venom gland 
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is encased in a fibrous sheath varying in position depending on species. The viperid 
gland is large, isosceles with the longest side along the upper lip directed dorsally; 
the gland is divided into lobules by the outer sheath with the lumen becoming a 
primary duct which passes through a mucous accessory duct into a secondary duct 
extending the length of the fang [43]. In contrast, the elapid venom gland is oval 
made from many branching tubules, its lumen is narrow and therefore most of the 
venom is stored in the surrounding cells [44]. The atractaspidid species possess a 
cylindrical gland extending posteriorly beyond the head, its lumen has a character-
istic pattern of unbranched tubules radiating outwards [45].
2.3 Snakebite classification
Bites can be classified as cytotoxic bites characterised by a painful swelling with 
watery blood leaking from the wound followed by shock, blistering and discoloura-
tion. Venomous snake bites in pregnant women can lead to poor survival rates in 
both the foetus and mother; early bites can precipitate teratogenesis, miscarriages, 
preterm delivery, foetal death and antepartum haemorrhage [46]. The bite will 
cause severe pain to the limb affected. Species associated with this bite include the 
puff adder, Gaboon adder and spitting cobras. Black and green mambas along with 
non-spitting cobras produce a neurotoxic bite in victims which leads to moderate 
swelling, cold and clammy extremities, dilated pupils and drooping of the eyelids. 
Patients suffering these bites will develop swollen lymph glands, vomiting, ptyalism 
and breathing difficulties. Haemotoxic bites associated with boomslang and vine 
snakes cause bleeding from the gums, nose, corner of eyes and old wounds and 
scratches. Certain snake species can produce more than one type of bites such as the 
Bitis arietans that produces a haemotoxic and cytotoxic bite [47].
2.4 Composition of snake venom
Medically significant venomous snakes are all front-fanged and are classified 
into three families: Atractaspididae, Elapidae and Viperidae; the glands of these 
snakes are homologous [48], with current evidence suggesting these evolved from 
non-front fanged venomous snakes [49]. These glands contain the snake venom, 
made from a combination of different protein families, each containing a variety of 
toxin isoforms along with carbohydrates, lipids, nucleosides and metals. Although 
homologous, the venom proteome is not due to the influence of genetic mutations 
and natural selection [50]. In a 2017 review, 59 protein families were identified in 
these three species, with four dominant proteins: phospholipase A2s, metalloprote-
ases, serine proteases and three-finger toxins; six secondary families: cysteine-rich 
secretory proteins, L-amino acid oxidases, Kunitz peptides, c-type lectins, disin-
tegrins and natriuretic peptides; nine minor proteins and 36 rare. Results revealed 
that elapid venom contained a less diverse range of protein families than the others, 
mostly consisting of phospholipases and three-finger toxins. Viper venom showed 
to scarcely contain three-finger toxin [51].
2.4.1 Phospholipase A₂
These enzymes play an important role in the regulation of phospholipid turn-
over, membrane permeability, cell maintenance and growth, apoptosis and the 
production of leukotrienes and prostaglandins [50]. Of the four types of PLAs, 
only type one and two are found in snake venom with several isoforms. These PLAs 
target the motor nerve terminal and the terminal part of the motor axon, by initiat-
ing hydrolysis of the lipids of the outer leaf of the plasma membrane of the nerve 
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terminal resulting in its depolarization. Synaptic vesicles are also destroyed by the 
PLA and the products of lipid hydrolysis [52]. Exposure of skeletal muscle to venom 
PLAs causes a severe inflammatory degenerative response, with the first clini-
cal signs apparent less than 1 hour after inoculation, with affected fibres rapidly 
depolarising [50].
2.4.2 Metalloprotease
Haemorrhaging is a common clinical sign associated with viper and crotaline 
snake bites and has been associated with the proteolytic activity of metalloprotease 
[53]. The proteases induce direct damage of the microvessels [54]. Snake venom 
metalloproteases are classified into four main groups based on their domain struc-
ture: PI—possesses a metalloprotease domain only, PII—consists of both metal-
loprotease and disintegrin-like domains, PIII—compromised of metalloprotease, 
disintegrin-like and high-cysteine domains, PIV—in addition to metalloprotease, 
disintegrin and cysteine also possesses a lectin-like polypeptide [53]. The disinteg-
rin-like domain inhibits platelet aggregation by binding to the fibrinogen receptor 
in platelet plasma membranes and although the role of the other domains is not 
clear, venoms with cysteine and disintegrin domains are more active at inducing 
haemorrhage than enzymes with only metalloprotease domains [55]. Investigations 
suggest pathogenesis is associated with a per rhexis mechanism whereby endothelial 
cells of capillary blood vessels rapidly thin and detach from surrounding basal 
lamina, progressive degeneration of these vessels leads to breaks in the endothelial 
lining, allowing blood to enter interstitial space [56].
2.4.3 Serine protease
Serine proteases are major components of snake venom, mostly identified in 
snakes of the Viperidae family and certain Elapidae, Colubridae and Hydrophiidae 
families [57]. These venom enzymes affect the haemostatic system by acting on the 
coagulation cascade and possess strong pro-coagulant effects through the activation 
of platelets, production of thrombin-like enzymes which clot fibrinogen and the 
creation anti-coagulant enzymes such as protein C [58], these serine protease pro-
duced thrombins are not susceptible to hirudin or heparin, other proteases possess 
kininogenase activity which releases hypotensive bradykinin [59].
2.4.4 Three-finger toxin (3FTs)
This family of non-enzymatic polypeptides exhibit potent toxic effects. Based 
on their biological properties, they can be classified as postsynaptic neurotoxins 
targeting the nicotinic and muscarinic acetylcholinesterase receptors; fasciculins 
targeting acetylcholinesterase; calciseptins and FS2 toxins targeting L-type cal-
cium channels; anticoagulants; β-blockers targeting β1 and β2 adrenergic receptors; 
dendroaspin targeting specific glycoproteins; cardiotoxin A5 targeting integrins 
and antagonists of α1A and α2A adrenergic receptors [60]. A large number of 3FTs 
are neurotoxic, interfering with cholinergic transmission at post-synaptic sites 
in the peripheral and central nervous system; mipartoxin-I, a 3FT, is the most 
abundant protein found in coral snake venom from northern South America and 
possesses a lethal effect in mice and a clear neuromuscular blockade in avian and 
mice subjects with an affinity for the cholinergic nicotinic receptor [61]. A group 
of cardiotoxic 3FTs found only in cobra venom is the second-largest group, at low 
concentrations they elevate heart rates and at high concentrations, cause death by 
cardiac arrest [62].
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2.5 The use of Bitis arietans snake venom in biopharmaceutical research
Biscetin, a platelet adhesion inducer, isolated from the venom of Bitis arietans 
has been shown to activate the binding of the Von Willebrand factor to glycoprotein 
without altering the binding site; this factor plays a key role in haemostatic response 
to vascular injury [63]. In a 2015 study, bitistatin a disintegrin isolated from the Puff 
adder was demonstrated to have an affinity for the integrin receptor avβ3, a marker 
used for tumour angiogenesis. This can be radiolabeled, injected and then detected 
on imaging. The ability to detect these receptors via diagnostic imaging has been 
used to successfully diagnose thrombosis in a canine model [64]. Studies research-
ing strategies to enhance immunological responses against venoms observed the 
cross-immunoreactivity of antivenoms of the Echis and Bitis species, supporting the 
hypothesis that immunising horses with a mixture of Echis ocellatus, Bitis arietans 
and Naja nigricollis generates enough antibodies that can recognise all medically 
relevant viper venoms in sub-Saharan Africa [65].
2.6 The Puff adder (Bitis arietans)
The Puff adder (Bitis arietans) is venomous snake from the Viperidae family 
found in the Middle East, North and sub-Saharan Africa. The species has a broad, 
flattened, lanceolate shaped head covered with small keeled scales attached to a 
narrow neck. Puff adders along with Russell’s vipers can make a loud hissing sound 
by expelling air through their large nostrils. These snakes are distinguishable by 
their distinctive repeated U or V dorsal pattern [66]. Bitis arietans feed on a variety 
of small animals including hares, hedgehogs, rodents, lizards and birds; they can 
actively forage by visiting birds’ nests to feed on eggs, nestling or the adult birds 
themselves. This species can also deploy ambush tactics by camouflaging them-
selves in areas where bird encounters are common, such as water pools [67].
2.7 The occurrence of snake bites
A global review by White in 2000 estimated that between 1.25 and 5.5 million 
snakebites occur annually [68]. These primarily occur in developing countries 
where there is a dense population of humans, an abundance of snakes and a lack of 
medical treatment facilities. In 1987 in South Africa, pregnant women accounted 
for 0–4% of cases admitted to hospital, in India, they accounted for 1% of admis-
sions [46]. Venomous snakebites may lead to poor foetal development and adversely 
affect the mother’s health; previous studies determined that foetal death occurred 
in 38–43% of snakebite cases, whereas maternal death accounted for 10% [69]. The 
African puff adder, along with the carpet viper, is the two most common species 
responsible for fatalities following bites in Africa. These adder venoms possess car-
diotoxic and haemorrhagic effects which can lead to hypovolemic shock, necrosis, 
systemic haemorrhage and arrhythmias [70].
2.8 The geographical variations in snake venom
Variation in venom composition occurs between species of snake as well as 
within a species. These variations can have a significant impact on venom toxicity 
and medical management. Different toxin-encoding genes in the genome attribute 
to these variations [28], however the mechanisms by which these gene expressions 
are controlled are poorly understood [71]. Results from Barlow et al. [72] provides 
evidence for the theory of diet affecting venom composition, by observing Echis 
snake species diet and the LD50 by which to incapacitate their natural scorpion 
Medical Toxicology
8
prey; their study findings suggested that variations in composition are derived 
from adaptive evolution, driven by natural selection, for different diets. It has more 
recently been hypothesised by other literature that variation in venom composition 
is the result of adaption to dietary selection [28]. In a 2015 study, the intraspecific 
variations of venom activities of E. ocellatus snakes from Nigeria and Cameroon 
were observed; the Nigerian venom showed higher lethality and coagulation in 
comparison to the Cameroonian venom. The antivenoms produced by both snakes 
were similarly effective in neutralising the venom, however, the coagulant activity 
was better neutralised by the Nigerian antivenom than the Cameroonian venom 
[73]. Further studies in geographical variations involving envenomation by N. naja 
revealed that the median lethal dose in mice differed between northern (0.55 mg/
kg), central (0.66), western (0.68), southern (0.62) and Sabaragamuwa (0.7) 
regions respectively. Histopathological changes of these regional venoms, however, 
showed a higher affinity for certain bodily systems, with northern venom observing 
a significantly higher infiltration of inflammatory and necrotic cells into skeletal 
muscle and central venom demonstrating high cardiotoxic effects, these results 
confirm venom disparity [74]. Geographical location showed a remarkable degree 
of variation amongst Bitis arietans species originating from the same geographical 
origin, most evident by the venom components metalloproteinases [71]. These 
metalloproteinases are responsible for inducing haemorrhaging, myonecrosis and 
degradation of extracellular matrix components which in turn affects local inflam-
matory response to a bite [53].
3. Materials and methods
3.1 Ethics and morality of research
In accordance with the European Union Directive 2010/63/EU section nine, 
embryos were not developed beyond the first two-thirds of development. This also 
corresponds with mandates of The Institutional Animal Care and Use Committee, 
Association of New England Medical Centre (Tufts) and the National Institute of 
Health, USA which dictate that a chick embryo that has not reached the 14th day of 
its gestation period will not experience pain and therefore can be used for experi-
mentation without ethical restrictions.
3.2 CHEST II
For this research, the chick embryotoxicity screening test was used. This stan-
dardised technique allows for the administration of small amounts of test com-
pounds into the fertilised egg on 4th embryonic day (ED4) and the measurement of 
a quantitative endpoint on ED9.
3.2.1 Materials
1. Fertilised eggs: alive and morphologically normal (breed Lohmann Brown, 
Hatchery Farm Párovské Háje, Nitra, Slovakia).
2. Incubator (ART 549/A).
3. Dissection kit: including tissue forceps, dissecting scissors and blunt scissors.
4. Micropipette with disposable tips.
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5. Stereomicroscope (Olympus SZ 61 with digital camera ARTCAM-300MI).
6. Observing dish with fixing pins.
7. Distilled water: to aid observation.
3.3 Application of snake venom: CHEST II
Eggs were placed in an incubator on day 0 at 37–38°C with a 50–60% relative 
humidity and rotated periodically until (ED4). Then eggs were removed and blunt 
end of eggs was cleaned with 70% alcohol and covered by a transparent adhesive 
tape. Subsequently, using serrated scissors (FST 14071-12), an opening was cut for 
application of the respective doses of snake venom (100 μl). The tested concentra-
tion was applied directly over the embryo on the top of inner shell membrane 
(membrana papyracea). Controls received the same volume of sterile distilled 
water—100 μl (Figure 1). The ranges of concentration as well as the total number 
of embryos and the days of application are listed in Tables 1 and 2. A small hole 
was then covered by micro-tape and labelled, before being returned to the incuba-
tor without rotation. On ED9 the eggs were removed from the incubator, the tape 
was removed and the survived chicken embryos were removed from the eggs using 
a crook, weighed and examined under a dissecting microscope. Hearts and liv-
ers were dissected from the chicken embryos and they were weighted separately 
(Figure 1).
3.4 Preparation of snake venom concentrations
Venoms from Bitis arietans (B.A.) of different regions were extracted in 
the breeding garden Pata near Hlohovec (Slovakia), which had been designed 
for reptiles’ conservation of the gene pool under the veterinary certificate No. 
CHEZ-TT-01. We used the snake venom of Bitis arietans from three different 
regions (Kenya, South Africa, Namibia). Also, we used one more snake venom 
sample without specific region determination (B.A. nonspecific). The breeding 
garden also serves as a quarantine station for imported animals and is an official 
importer of exotic animals from around the world, having the permission of the 
State Nature Protection of the Slovak Republic under the No. 03418/06, the trade 
with endangered species of wild fauna and flora and on amendments to certain laws 
under Law No. 237/2002.
Figure 1. 
Graphical illustration of snake venom administration on ED4 (A) and visualisation of developing heart and 
liver on ED9 (B); asterisk—lobes of liver, h—heart.
Medical Toxicology
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A sterile plastic cup was used for venom extraction with plastic food wrap, and 
rubber bands fixed the plastic wrap. For the application, we used snake venoms 
immediately after their extracting. Before use, it was ensured the venoms were 
continuously kept in cold storage to ensure that they retained their full toxicological 






















0 10 1 10 1.73 22.9 31.6
100 10 7 70 1.42 16.3 20.7
10 10 3 30 1.66 18.3 20.9
1 10 2 20 1.59 17.0 19.9




0 10 1 10 1,53 18.7 28.5
100 10 2 20 1.16 13.5 15.5
10 10 4 40 1.19 13.3 14.8
1 10 1 10 1.19 15.6 14.2




0 10 1 10 1.62 18.0 28.8
100 10 2 20 1.67 18.5 19.3
10 10 2 20 1.62 19.9 19.6
1 10 2 20 1.66 19.9 26.8




0 10 1 10 1.70 21.0 31.2
100 10 2 20 1.47 17.3 20.8
10 11 3 27 1.72 20.6 35.3
1 11 1 9 1.60 20.1 31.4
0.1 11 2 18 1.54 20.1 30.1
Total 203 41
N, number of chicken embryos; numbers in bold represent statistically significant results (P ≤ 0.05).
Table 2. 
Embryotoxic effect of Bitis arietans venom from different regions of Africa.
Snake venom Concentrations (mg/ml)
E-1 E-2 E-3 E-4
Control (sterile distilled water)
B.A. nonspecific region 100.00 10.00 1.00 0.10
B.A. Kenya 100.00 10.00 1.00 0.10
B.A. Namibia 100.00 10.00 1.00 0.10
B.A. South Africa 100.00 10.00 1.00 0.10
Table 1. 
Concentrations of snake venom used for each venom.
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potential. The venoms were diluted with sterile distilled water to give equal con-
centrations (based on molecular weights) of E-1, E-2, E-3 and E-4 when required 
(Table 1). The composition of tested snake venoms used in our study has been 
already described and determined in previous studies [75, 76].
3.5 Nile blue staining
For this staining method, embryos with the highest concentration of snake 
venom (10-1) were used. The blue stain was applied on ED4. The embryos were 
then dissected on day ED6 and incubated in a 1/8000 solution of Nile Blue A 
(Sigma) and PBS for 15 minutes at 37°C in an incubator. Following this, embryos 
were transferred to cold PBS (4 °C) and washed for 4 hours. Embryos were 
then photographed with a stereomicroscope Olympus SZ 61 with digital camera 
ARTCAM-300MI and Quick Photo 2.3 software. These embryos were lastly 
compared with control embryos (sterile distilled water applied only) dissected 
on ED6.
3.6 Evaluation
The number of dead or growth-retarded embryos (those <650 mg) were totalled for 
each concentration. The proportion of effects on heart and liver in surviving embryos 
were considered separately to establish a profile of each concentration. The result of the 
CHEST was rank venom in order of their teratogenic potency in chickens; these ranges 
can be compared for an assessment of human risk. For statistical analysis, the pro-
gramme GraphPad Prism 6.0 was utilised (one-way ANOVA, with a P-value of 0.05).
4. Results
The following results were analysed—body weight, heart weight and liver 
weight. These results were compared between control samples and the venom of 
Bitis arietans from four different regions of Africa (Namibia, Kenya, South Africa 
and non-specified region).
4.1 Body weight
All living embryos were weighed on ED 9 in grams. Figure 2 presents the follow-
ing concentrations E1 (10-1), E2 (10-2), E3 (10-3) and E4 (10-4).
4.1.1 Kenya
The average body weight of the control embryos was 1.73 g, whereas embryos 
infused with venom concentration 10-1 (E1), 10-2 (E2) and 10-3 (E3) were signifi-
cantly reduced (P < 0.05) in comparison. E1 averaged at 1.15 g in body weight, E2 
was slightly increased at 1.18 g and E3 at 1.19 g. There was a large increase between 
E3 and 10-4 (E4) body weight, with E4 averaging at 1.5 g.
4.1.2 Namibia
The embryos injected with venoms of the Namibian snake showed no statisti-
cally significant changes in body weight in comparison with the control embryos. 
E1 body weight averaged at 1.4 g in comparison with the 1.72 g of control embryos. 
E2 average body weight was 1.7 g whereas E3 averaged at 1.6 g. E4 embryos body 




None of the embryos impregnated with South African Puff adder venom 
showed a statistically significant change in body weight compared to the control 
group. E1, E2 and E3 body weights were all similar, averaging at 1.67, 1.62 and 1.66 g 
respectively. E4 averaged the smallest body weight at 1.43 g.
4.1.4 Non-specific region
None of the embryos infused with the non-specific venom showed significant 
differences in body weight compared to the control group. E1 averaged the smallest 
body weight at 1.42 g, E2 averaged at 1.66 g, E3 at 1.58 g and E4 at 1.66 g.
4.2 Heart weight
Hearts were cut from surviving embryos at the level of the aorta and weighed in 
milligrams (Figure 3).
4.2.1 Kenya
The control heart mean weighed 23 mg; the embryo hearts infused with venom 
were significantly smaller in E1, E2 and E3. E1 and E2 weighed in at 13 mg, E3 had 
a slight increase in weight at 15 mg. There was a large increase between E3 and E4 
with the latter averaging 18 mg.
4.2.2 Namibia
None of the concentrations had a significant effect on heart weight in compari-
son to the control group. E1 mean heart weight came in at 17 mg. E2 was the largest 
weights at 21 mg, E3 and E4 averaged 20 mg.
4.2.3 South Africa
The largest average heart weight was seen in E3 and E2 at 19.8 mg. E1 averaged 
at 18.5 mg. E4 had the lowest body weight of 15 mg; this result was statistically 
significant.
4.2.4 Non-specified region
E1 and E3 results were both deemed statistically significant. E1 averaged the 
lowest heart weight of 16 mg. E2 averaged 18 mg whereas E3 mean was lower than 
E2 at 17 mg. E4 weighed in with the largest heart weight of 18 mg.
4.3 Liver weight
Livers were cut at the level of the portal vein, cut from surviving embryos and 
weighed in milligrams (Figure 4).
4.3.1 Kenya
All four concentrations of snake venom s were proven statistically significant. 
The mean control group liver weighed 31.6 mg, larger than all four test groups. E1 
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Figure 3. 
Graphs depicting heart weights of the Bitis arietans venoms of Kenya, non-specified (NS), South Africa (SA) 
and Namibia, (*): Statistically significant (P ≤ 0.05).
Figure 2. 
Graphs depicting body weights of the Bitis arietans venoms of Kenya, non-specified (NS), South Africa (SA) 
and Namibia, (*): statistically significant (P ≤ 0.05).
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liver weight mean was recorded as 15.5 mg, E2 weighed in at 14.8 mg; E3 was the 
lowest average liver weight of 14 mg. E4 average liver weight was the largest at 20 mg.
4.3.2 Namibia
Venom concentration E1 was the only statistically significant result in this test 
group, with its average weight calculated at 20 mg. E2 liver weight averaged heavier 
than the control group (31.6 mg) with 35 mg. E3 mean weight was similar to the 
control at 31.4 mg and E4 averaged 30 mg.
4.3.3 South Africa
E1, E2 and E4 concentrations were proven statistically significant; whereas E3, 
with the largest liver weight of 26 mg, was not. E1 had the lowest average liver weight 
of 19.2 mg; E2 was marginally heavier at 19.8 mg. E4 liver weight averaged at 20.7 mg.
4.3.4 Non-specified region
Three of the four concentrations of non-specified venom had a statistically 
significant effect on the liver weight (E2, E3 and E4). E1 mean result weighed in at 
20 mg; E2 was faintly heavier at 20.9 mg. E3 weighed the least with 19.9 mg. E4 had 
the heaviest weight within the test group at 22.2 mg.
4.4 Mortality rates
The highest mortality rate was seen in the highest concentration, in this maxi-
mum venom concentration (E1) the non-specific venom samples had a 70% death 
Figure 4. 
Graphs depicting liver weights of the Bitis arietans venoms of Kenya, non-specified (NS), South Africa (SA) 
and Namibia, (*): Statistically significant (P ≤ 0.05).
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occurrence (embryos not surviving to day 9); the Kenyan, Namibian and South 
African E1 all had a 20% mortality rate. All groups at each concentration had a 
fatality, except the South African E4 group.
The non-specified venom produced the highest overall amount of fatalities, 
with the Kenyan being second, Namibian third and South African venom being 
the least lethal. The 10 mg/ml (E2) concentration saw the highest mortality rates 
overall, with the Kenyan test group showing a 40% mortality, the Namibian and 
non-specific test group perceiving 30% mortality and the South African group a 
20% mortality. E3 showed 20% fatality in the South African and non-specific test 
groups, in Namibia and Kenyan groups only 10% fatality rate was recorded. In the 
lowest concentration (E4) the highest mortality rate was recorded in the Kenyan 
group with 30%. No fatalities were recorded in the South African group. The 
Namibian test group showing a 20% mortality and the non-specific test group a 
10% mortality (Figure 5, Table 2).
4.5 Nile blue staining
The embryos were stained on ED4 and removed from their eggs on ED6; all were 
envenomed with the strongest concentrations of venom (10-1; Figure 6).
Figure 5. 
Mortality rates of chicken embryos against snake venom.
Figure 6. 
Nile blue staining results. (a) Control, (b) B.A. nonspecific region, (c) B.A. South Africa, (d) B.A. Kenya,  
(e) B.A. Namibia; asterisk—wing and leg buds on ED9, arrows—dark coloured areas with apoptotic response.
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The arrows on the above images highlight the darkened areas of apoptotic cells. 
These images show that initial cell death is initiated on the wing buds. The control 
embryo (a), infused with distilled sterile water only, demonstrates no apoptosis. 
The nonspecific venom (b) indicates a small amount of apoptosis located on the 
wing buds. Embryos envenomed with South African (c) and Kenyan (d) B.A. 
showed significant apoptosis along with the entire wing buds, with the Kenyan 
spreading to the extremities. The Namibian embryo showed less severe cell apopto-
sis than (c) and (d) along with the wing buds.
5. Discussion
5.1 Bodyweight
Although the body weights varied amongst regional snakes and concentrations, 
they all presented similarly which was anticipated as they are the same species of 
snake. Generalised haemorrhaging was present across all four venom groups, which 
was expected due to the haemotoxic nature of Bitis arietans [47]. The Kenyan test 
group was the only one to have statistically significant changes in body weight with 
envenomation (E1, E2 and E3); the average weights for this group were also notably 
smaller than the rest, suggesting a larger detrimental effect than the other venom 
groups. The South African, Namibian and non-specific groups had similar mean 
weights across all four concentrations, which could propose a similar toxicity level 
across these regions. Further research into regional diet variations could strengthen the 
hypothesis that venom composition is derived from a natural dietary selection [28].
5.2 Heart weight
All heart weights of embryos envenomed with Bitis arietans were reduced, with 
the Kenyan group showing the highest rate of statistical significance, with E1, E2 
and E3 all being significant; this group also presented the lowest mean weights at 
13–15 mg. These findings support the proposal that the Kenyan venom has a stron-
ger effect than the other regions. A histopathological study observed that Vipera 
raddei, from the family Viperidae, venom caused cardiomyocyte disruption, fibrosis 
and blood vessel congestion in post mortem specimens [77]. Another study found 
Naja nigricollis venom injected into pregnant mice caused hepatic and myocardial 
damage as well as pulmonary vascular congestion and accumulation of blood in 
the intestinal lumen of the foetus [78]. One of the venom components of Bitis 
arietans is a serine protease, a bioactive protein, which plays a role in the regula-
tion of the blood coagulation cascade and affects the circulatory haemostasis [59]. 
Disturbances by these proteins could lead to adverse effects on embryonic organ 
development, which may account for the reduction in heart weights; however, to 
date, no studies are focusing on the effects of snake venom on the heart function.
5.3 Liver weight
All groups had a minimum of one statistically significant concentration, sug-
gesting the liver was the most affected parameter (in comparison with heart and 
body weight). In furtherance with the proposal that the Kenyan venom has the 
highest potency, E1, E2 and E3 all proved statistically significant as well as being 
of the lowest median body weights of the groups surveyed. All livers exhibited 
a decrease in mean weight, varying yellow colour change along with increased 
susceptibility to disintegration on removal; this substantiates the results from 
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a previous study on the effects of Echis coloratus venom on sheep liver, where 
biochemical and histological alterations were observed. The study reported an 
elevation in glucose, aspartate aminotransferase, alanine transferase, triglyceride 
and total bilirubin whilst cholesterol levels were reduced. Histologically, pyknosis, 
karyorrhexis, cytoplasmic vacuolation, necrosis, fatty changes and hepatocyte 
atrophy were observed [79].
5.4 Mortality
The highest incidence of mortality was observed in E1 by the non-specified test 
group, with a 70% mortality; whereas Kenya, Namibia and South Africa observed a 
40–10% death rate. This evidence proposes that although the Kenyan venom has the 
most significant impact on development, the non-specific venom has the strongest 
potency. Furthers study with a larger specimen pool is needed to confirm these 
findings.
5.5 Apoptotic cell appearance (Nile blue staining)
A 1993 study observed that haemorrhagic snake venom (Bitis arietans) induced 
apoptosis of vascular endothelial cells whereas neurotoxic venom did not induce 
programmed cell death; instead it caused necrosis at much higher doses of venom 
[80]. This corroborates with the findings of the Nile blue staining of this study 
which revealed varying levels of cell death along with the wing buds and limb 
extremities of Bitis arietans envenomed embryos. The development of limb vascu-
lature may explain why apoptosis was seen the distal limbs, clustered away from the 
tips of the extremities. Interestingly, apoptosis was primarily seen on the wing buds, 
which develop later than the legs [81]. Previous studies may have explained the 
affinity for wing bud cells over leg bud cells due to the principle of non-equivalence 
meaning that cells in different areas of the body have different intrinsic characters 
and positional information [82]; however it has more recently been proven that 
these cells are interchangeable and not restricted in their development [83].
6. Conclusions
In conclusion, it was seen that the test group envenomed by Bitis arietans from 
Kenya exhibited the highest incidence of detrimental effects. Concentration 100, 
10 and 1 mg/ml of venom all showed statistically significant changes to the body, 
heart and liver weight. This venom also produced the smallest average weights 
in comparison to the other test groups. The highest mortality rate, however, was 
observed in the non-specific venom, with the strongest concentration resulting in 
70% fatalities. This suggests that the most fatal of the four venoms observed was the 
non-specific African Bitis arietans. The induced cell death was observed in all four 
venom specimens, which correlates to Bitis arietans previously documented haemo-
toxic potential. The results showed that the Kenyan venom, along with having the 
most significant effect on organ weights of the embryo, also initiated the strongest 
apoptosis.
These results suggest a geographical variation in potency of Bitis arietans venom, 
however further study is required to determine the cause of this variation. Current 
hypotheses suggest a natural dietary evolution influencing the venom composi-
tion; future studies examining if there is a regional difference in the diet of these 
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